About the Authors

Leonie Callaway
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia

Leonie Callaway, Paul B. Colditz, Nicholas M. Fisk
Royal Brisbane & Women's Hospital, Herston, Queensland, Australia

Paul B. Colditz, Nicholas M. Fisk
University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia

Corresponding Author

n.fisk@uq.edu.au

Competing Interests

LC declares that she has no competing interests related to this Perspective. PBC was involved with the Micronutrient Initiative in lobbying for flour fortification in Australia and New Zealand. NMF was a member of the UK Advisory Board of Ferring Pharmaceuticals until 2007, has received recent travel funds from Ferring International, the Royal College of Obstetricians and Gynaecologists, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, and the North American Fetal Treatment Network, and acts as an expert witness in medicolegal litigation in obstetrics. Between 1996–2002, he was a member of a UK lobby group (chair Prof. N. Wald) to enrich commercial flour to prevent spina bifida.

Author Contributions

ICMJE criteria for authorship read and met: LC NMF PBC. Wrote the first draft of the paper: LC NMF. Contributed to the writing of the paper: PBC.